Abstract
Several indole derivatives and analogues comprising a range of related structural classes were designed, synthesized and tested as ligands for the 5-HT4 receptor. Within each series, binding experiments showed compounds with good affinity demonstrating high percentage displacement values at 1 µM. The most potent of these (20) had a pKi of 8.54 demonstrating very good affinity. These indole analogues were combined with 55 ligands that were previously produced in our laboratory to explore the structure-activity relationships of these 5-HT4 ligands. A CoMFA (Comparative Molecular Field Analysis) analysis was used to extend an earlier simple pharmacophore to suggest two new molecular features beyond the primary amino binding site. The pharmacophore confirmed that a newly described tetrahydroquinoline analogue was able to match the basic requirements of the model and the pharmacology of this molecule is provided in more detail.
Keywords: 5-HT4 ligands, radioligand binding, CoMFA, pharmacophore, molecular modelling, tetrahydroquinoline, gastroesophageal reflux disease, irritable bowel syndrome, TopCount Microplate Scintillation Counter, cisapride, metoclopramide, NMR spectrometer, Micromass Platform II single quadrupole mass spectrometer, electrospray, column chromatography
Medicinal Chemistry
Title: Synthesis, Testing and Structure-Activity Studies on a Library of 5-HT4 Ligands
Volume: 6 Issue: 6
Author(s): Amir Hanna-Elias, David T. Manallack, Alla Levit, William Nguyen, Fadi Ayad, Glen Perera, Marina Shapiro, Helen R. Irving, Ian M. Coupar and Magdy N. Iskander
Affiliation:
Keywords: 5-HT4 ligands, radioligand binding, CoMFA, pharmacophore, molecular modelling, tetrahydroquinoline, gastroesophageal reflux disease, irritable bowel syndrome, TopCount Microplate Scintillation Counter, cisapride, metoclopramide, NMR spectrometer, Micromass Platform II single quadrupole mass spectrometer, electrospray, column chromatography
Abstract: Several indole derivatives and analogues comprising a range of related structural classes were designed, synthesized and tested as ligands for the 5-HT4 receptor. Within each series, binding experiments showed compounds with good affinity demonstrating high percentage displacement values at 1 µM. The most potent of these (20) had a pKi of 8.54 demonstrating very good affinity. These indole analogues were combined with 55 ligands that were previously produced in our laboratory to explore the structure-activity relationships of these 5-HT4 ligands. A CoMFA (Comparative Molecular Field Analysis) analysis was used to extend an earlier simple pharmacophore to suggest two new molecular features beyond the primary amino binding site. The pharmacophore confirmed that a newly described tetrahydroquinoline analogue was able to match the basic requirements of the model and the pharmacology of this molecule is provided in more detail.
Export Options
About this article
Cite this article as:
Hanna-Elias Amir, T. Manallack David, Levit Alla, Nguyen William, Ayad Fadi, Perera Glen, Shapiro Marina, R. Irving Helen, M. Coupar Ian and N. Iskander Magdy, Synthesis, Testing and Structure-Activity Studies on a Library of 5-HT4 Ligands, Medicinal Chemistry 2010; 6 (6) . https://dx.doi.org/10.2174/157340610793563965
DOI https://dx.doi.org/10.2174/157340610793563965 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting
Current Molecular Pharmacology Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets Epidemiology and Costs of Hypertension-related Disorders
Current Pharmaceutical Design Targeting Mitochondrial Biogenesis to Treat Insulin Resistance
Current Pharmaceutical Design A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Current Pharmaceutical Design Experimental Research on Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge
CNS & Neurological Disorders - Drug Targets Gene therapy for Multiple Myeloma
Current Gene Therapy Molecular Genetic of Human Male Infertility: From Genes to New Therapeutic Perspectives
Current Pharmaceutical Design Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis
Endocrine, Metabolic & Immune Disorders - Drug Targets Amyloid β-Peptide: The Inside Story
Current Alzheimer Research Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics Clozapine Safety, 40 Years Later
Current Drug Safety Impact of Antiretroviral Therapy on the Relapse of Cryptococcosis and Survival of HIV-Infected Patients with Cryptococcal Infection
Current HIV Research Metabolic Control of Glia-Mediated Neuroinflammation
Current Alzheimer Research Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
Current Pharmaceutical Design Hormone Responsive Breast Cancer and BRCA1 Mutation: Mechanism, Regulation and Iron-mediated Effects
Current Pharmaceutical Biotechnology Substance-Induced Psychoses: A Critical Review of the Literature
Current Drug Abuse Reviews Research Toward Potassium Channels on Tumor Progression
Current Topics in Medicinal Chemistry